Exact Mass: 574.3175

CucurbitacinA

C32H46O9 (574.3142)

Cucurbitacin A is a cucurbitacin. Cucurbitacin A is a natural product found in Hintonia standleyana, Cucumis prophetarum, and other organisms with data available.

Herbimycin

C30H42N2O9 (574.289)

A 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It is an ansamycin antibiotic that induces apoptosis and displays antitumour effects. C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

Ganoderic acid K

C32H46O9 (574.3142)

Ganoderic acid K is found in mushrooms. Ganoderic acid K is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid K is found in mushrooms.

Ganoderic acid alpha

C32H46O9 (574.3142)

Ganoderic acid alpha is found in mushrooms. Ganoderic acid alpha is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). Ganoderic acid alpha is found in mushrooms.

Cyclo(Arg-Gly-Asp-D-Phe-Val)

C26H38N8O7 (574.2863)

herbimycin a

C30H42N2O9 (574.289)

3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione

C31H38N6O5 (574.2904)

PA(8:0/18:2(10E,12Z)+=O(9))

C29H51O9P (574.3271)

PA(8:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(10E,12Z)+=O(9)/8:0)

C29H51O9P (574.3271)

PA(18:2(10E,12Z)+=O(9)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/8:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:2(9Z,11E)+=O(13))

C29H51O9P (574.3271)

PA(8:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(9Z,11E)+=O(13)/8:0)

C29H51O9P (574.3271)

PA(18:2(9Z,11E)+=O(13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/8:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:3(10,12,15)-OH(9))

C29H51O9P (574.3271)

PA(8:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(10,12,15)-OH(9)/8:0)

C29H51O9P (574.3271)

PA(18:3(10,12,15)-OH(9)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/8:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:3(9,11,15)-OH(13))

C29H51O9P (574.3271)

PA(8:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(9,11,15)-OH(13)/8:0)

C29H51O9P (574.3271)

PA(18:3(9,11,15)-OH(13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/8:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Cucurbitacin A

C32H46O9 (574.3142)

Cucurbitacin a is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin a is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin a can be found in cucumber, which makes cucurbitacin a a potential biomarker for the consumption of this food product.

Galphimine G

C32H46O9 (574.3142)

Galphimine D

C32H46O9 (574.3142)

2-O-Acetylcerleaside A

C32H46O9 (574.3142)

Meliavolkinin

C35H42O7 (574.293)

Cephalosporin P1

C33H50O8 (574.3506)

Galphimine I

C32H46O9 (574.3142)

Galphimine E

C32H46O9 (574.3142)

Tricalysioside O

C28H46O12 (574.2989)

13beta,29-Dihydroxymilbemycin A4

C32H46O9 (574.3142)

Cucurbitacin

C33H50O8 (574.3506)

Spirostan-2,3,27-triol, triacetate, (2.alpha.,3.beta.,5.alpha.,25S)-

C33H50O8 (574.3506)

dichrostachine P

C35H42O7 (574.293)

Piscidinol D

C32H46O9 (574.3142)

Isocephalosporin P(1)

C33H50O8 (574.3506)

30-hydroxy petuniasterone A

C32H46O7S (574.2964)

Anhydrodebromoaplysiatoxin

C32H46O9 (574.3142)

3-epi-Sceptrumgenin-3-beta-D-glucopyranosid

C33H50O8 (574.3506)

1-benzoyl-2-methoxy-8,8-dimethyl-4,5-bis(3-methylbut-2-enyl)-7-[(3-methyl-4-acetoxy-but-2-enyl)]endo-bicyclo[3.3.1]non-2-ene-4,9-dione

C36H46O6 (574.3294)

Thesine

C34H42N2O6 (574.3043)

Brasiliensophyllic acid C

C36H46O6 (574.3294)

3beta-O-(2-O-acetyl-alpha-L-thevetosyl)-14beta-hydroxy-7-en-5beta-card-20(22)-enolide|3??-O-(2-O-Acetyl-??-L-thevetosyl)-14??-hydroxy-7-en-5??-card-20(22)-enolide|7,8-dehydrocerberin

C32H46O9 (574.3142)

Phytolaccagenin A

C33H50O8 (574.3506)

15alpha-hydroxy-16-dehydroxy-16(24)-en-foetidinol-3-O-beta-D-xylopyranoside

C32H46O9 (574.3142)

C34H42N2O6

C34H42N2O6 (574.3043)

microginin 91-A

C28H51ClN4O6 (574.3497)

17beta-hydroxypetuniasterone A

C32H46O7S (574.2964)

7beta-hydroxycucurbitacin B

C32H46O9 (574.3142)

6-O-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside

C28H46O12 (574.2989)

brujavanone D

C33H50O8 (574.3506)

Plocigenin

C35H42O7 (574.293)

butyl lucidenate P

C33H50O8 (574.3506)

Teraspiridole B_130089

C34H42N2O6 (574.3043)

12-O-decanoyl-7-oxo-5-ene-phorbol-13-acetate|12-O-neodecanoyl-7-oxo-5-enephorbol-13-acetate|daphwanin

C32H46O9 (574.3142)

C32H46O9

C32H46O9 (574.3142)

3beta-O-(2-O-acetyl-alpha-L-acofriosyl)-16-anhydrogitoxigenin|vallarisoside

C32H46O9 (574.3142)

milbemycin beta10

C33H50O8 (574.3506)

Turbicoryn

C29H50O11 (574.3353)

C30H42N2O9

C30H42N2O9 (574.289)

inocalophyllin A methyl ester

C36H46O6 (574.3294)

Ile Ile Arg Ser Ser

C24H46N8O8 (574.3438)

Glu Asp Arg Arg

C21H38N10O9 (574.2823)

Met Leu Arg Ala Ala

C24H46N8O6S (574.3261)

Asp Lys Leu Gly Glu

C24H42N6O10 (574.2962)

Val Leu Lys Asp Ser

C25H46N6O9 (574.3326)

Asp Gln Val Leu Ser

C24H42N6O10 (574.2962)

Thr Pro Thr Glu Lys

C24H42N6O10 (574.2962)

Lys Leu Glu Ala Thr

C25H46N6O9 (574.3326)

Lys Asn Asn Thr Val

C23H42N8O9 (574.3075)

Glu Arg Ile Ala Ser

C23H42N8O9 (574.3075)

Glu Glu Val Lys Ala

C24H42N6O10 (574.2962)

Ganoderic acid alpha

C32H46O9 (574.3142)

Ganoderic Acid K

C32H46O9 (574.3142)

Ala Ile Trp Trp

C31H38N6O5 (574.2904)

Ala Leu Trp Trp

C31H38N6O5 (574.2904)

Ala Trp Ile Trp

C31H38N6O5 (574.2904)

Ala Trp Leu Trp

C31H38N6O5 (574.2904)

Ala Trp Trp Ile

C31H38N6O5 (574.2904)

Ala Trp Trp Leu

C31H38N6O5 (574.2904)

Asp Arg Val Trp

C26H38N8O7 (574.2863)

Asp Arg Trp Val

C26H38N8O7 (574.2863)

Asp Val Arg Trp

C26H38N8O7 (574.2863)

Asp Val Trp Arg

C26H38N8O7 (574.2863)

Asp Trp Arg Val

C26H38N8O7 (574.2863)

Asp Trp Val Arg

C26H38N8O7 (574.2863)

Glu Ile Lys Trp

C28H42N6O7 (574.3115)

Glu Ile Trp Lys

C28H42N6O7 (574.3115)

Glu Lys Ile Trp

C28H42N6O7 (574.3115)

Glu Lys Leu Trp

C28H42N6O7 (574.3115)

Glu Lys Trp Ile

C28H42N6O7 (574.3115)

Glu Lys Trp Leu

C28H42N6O7 (574.3115)

Glu Leu Lys Trp

C28H42N6O7 (574.3115)

Glu Leu Trp Lys

C28H42N6O7 (574.3115)

Glu Trp Ile Lys

C28H42N6O7 (574.3115)

Glu Trp Lys Ile

C28H42N6O7 (574.3115)

Glu Trp Lys Leu

C28H42N6O7 (574.3115)

Glu Trp Leu Lys

C28H42N6O7 (574.3115)

Phe Pro Arg Arg

C26H42N10O5 (574.3339)

Phe Arg Pro Arg

C26H42N10O5 (574.3339)

Phe Arg Arg Pro

C26H42N10O5 (574.3339)

His Lys Lys Tyr

C27H42N8O6 (574.3227)

His Lys Gln Tyr

C26H38N8O7 (574.2863)

His Lys Tyr Lys

C27H42N8O6 (574.3227)

His Lys Tyr Gln

C26H38N8O7 (574.2863)

His Gln Lys Tyr

C26H38N8O7 (574.2863)

His Gln Tyr Lys

C26H38N8O7 (574.2863)

His Tyr Lys Lys

C27H42N8O6 (574.3227)

His Tyr Lys Gln

C26H38N8O7 (574.2863)

His Tyr Gln Lys

C26H38N8O7 (574.2863)

Ile Ala Trp Trp

C31H38N6O5 (574.2904)

Ile Glu Lys Trp

C28H42N6O7 (574.3115)

Ile Glu Trp Lys

C28H42N6O7 (574.3115)

Ile Lys Glu Trp

C28H42N6O7 (574.3115)

Ile Lys Trp Glu

C28H42N6O7 (574.3115)

Ile Met Arg Arg

C23H46N10O5S (574.3373)

Ile Arg Met Arg

C23H46N10O5S (574.3373)

Ile Arg Arg Met

C23H46N10O5S (574.3373)

Ile Arg Thr Trp

C27H42N8O6 (574.3227)

Ile Arg Trp Thr

C27H42N8O6 (574.3227)

Ile Thr Arg Trp

C27H42N8O6 (574.3227)

Ile Thr Trp Arg

C27H42N8O6 (574.3227)

Ile Trp Ala Trp

C31H38N6O5 (574.2904)

Ile Trp Glu Lys

C28H42N6O7 (574.3115)

Ile Trp Lys Glu

C28H42N6O7 (574.3115)

Ile Trp Arg Thr

C27H42N8O6 (574.3227)

Ile Trp Thr Arg

C27H42N8O6 (574.3227)

Ile Trp Trp Ala

C31H38N6O5 (574.2904)

Lys Glu Ile Trp

C28H42N6O7 (574.3115)

Lys Glu Leu Trp

C28H42N6O7 (574.3115)

Lys Glu Trp Ile

C28H42N6O7 (574.3115)

Lys Glu Trp Leu

C28H42N6O7 (574.3115)

Lys His Lys Tyr

C27H42N8O6 (574.3227)

Lys His Gln Tyr

C26H38N8O7 (574.2863)

Lys His Tyr Lys

C27H42N8O6 (574.3227)

Lys His Tyr Gln

C26H38N8O7 (574.2863)

Lys Ile Glu Trp

C28H42N6O7 (574.3115)

Lys Ile Trp Glu

C28H42N6O7 (574.3115)

Lys Lys His Tyr

C27H42N8O6 (574.3227)

Lys Lys Asn Trp

C27H42N8O6 (574.3227)

Lys Lys Trp Asn

C27H42N8O6 (574.3227)

Lys Lys Tyr His

C27H42N8O6 (574.3227)

Lys Leu Glu Trp

C28H42N6O7 (574.3115)

Lys Leu Trp Glu

C28H42N6O7 (574.3115)

Lys Asn Lys Trp

C27H42N8O6 (574.3227)

Lys Asn Gln Trp

C26H38N8O7 (574.2863)

Lys Asn Trp Lys

C27H42N8O6 (574.3227)

Lys Asn Trp Gln

C26H38N8O7 (574.2863)

Lys Gln His Tyr

C26H38N8O7 (574.2863)

Lys Gln Asn Trp

C26H38N8O7 (574.2863)

Lys Gln Trp Asn

C26H38N8O7 (574.2863)

Lys Gln Tyr His

C26H38N8O7 (574.2863)

Lys Trp Glu Ile

C28H42N6O7 (574.3115)

Lys Trp Glu Leu

C28H42N6O7 (574.3115)

Lys Trp Ile Glu

C28H42N6O7 (574.3115)

Lys Trp Lys Asn

C27H42N8O6 (574.3227)

Lys Trp Leu Glu

C28H42N6O7 (574.3115)

Lys Trp Asn Lys

C27H42N8O6 (574.3227)

Lys Trp Asn Gln

C26H38N8O7 (574.2863)

Lys Trp Gln Asn

C26H38N8O7 (574.2863)

Lys Tyr His Lys

C27H42N8O6 (574.3227)

Lys Tyr His Gln

C26H38N8O7 (574.2863)

Lys Tyr Lys His

C27H42N8O6 (574.3227)

Lys Tyr Gln His

C26H38N8O7 (574.2863)

Leu Ala Trp Trp

C31H38N6O5 (574.2904)

Leu Glu Lys Trp

C28H42N6O7 (574.3115)

Leu Glu Trp Lys

C28H42N6O7 (574.3115)

Leu Lys Glu Trp

C28H42N6O7 (574.3115)

Leu Lys Trp Glu

C28H42N6O7 (574.3115)

Leu Met Arg Arg

C23H46N10O5S (574.3373)

Leu Arg Met Arg

C23H46N10O5S (574.3373)

Leu Arg Arg Met

C23H46N10O5S (574.3373)

Leu Arg Thr Trp

C27H42N8O6 (574.3227)

Leu Arg Trp Thr

C27H42N8O6 (574.3227)

Leu Thr Arg Trp

C27H42N8O6 (574.3227)

Leu Thr Trp Arg

C27H42N8O6 (574.3227)

Leu Trp Ala Trp

C31H38N6O5 (574.2904)

Leu Trp Glu Lys

C28H42N6O7 (574.3115)

Leu Trp Lys Glu

C28H42N6O7 (574.3115)

Leu Trp Arg Thr

C27H42N8O6 (574.3227)

Leu Trp Thr Arg

C27H42N8O6 (574.3227)

Leu Trp Trp Ala

C31H38N6O5 (574.2904)

Met Ile Arg Arg

C23H46N10O5S (574.3373)

Met Leu Arg Arg

C23H46N10O5S (574.3373)

Met Arg Ile Arg

C23H46N10O5S (574.3373)

Met Arg Leu Arg

C23H46N10O5S (574.3373)

Met Arg Arg Ile

C23H46N10O5S (574.3373)

Met Arg Arg Leu

C23H46N10O5S (574.3373)

Asn Lys Lys Trp

C27H42N8O6 (574.3227)

Asn Lys Gln Trp

C26H38N8O7 (574.2863)

Asn Lys Trp Lys

C27H42N8O6 (574.3227)

Asn Lys Trp Gln

C26H38N8O7 (574.2863)

Asn Gln Lys Trp

C26H38N8O7 (574.2863)

Asn Gln Trp Lys

C26H38N8O7 (574.2863)

Asn Trp Lys Lys

C27H42N8O6 (574.3227)

Asn Trp Lys Gln

C26H38N8O7 (574.2863)

Asn Trp Gln Lys

C26H38N8O7 (574.2863)

Pro Phe Arg Arg

C26H42N10O5 (574.3339)

Pro Arg Phe Arg

C26H42N10O5 (574.3339)

Pro Arg Arg Phe

C26H42N10O5 (574.3339)

Gln His Lys Tyr

C26H38N8O7 (574.2863)

Gln His Tyr Lys

C26H38N8O7 (574.2863)

Gln Lys His Tyr

C26H38N8O7 (574.2863)

Gln Lys Asn Trp

C26H38N8O7 (574.2863)

Gln Lys Trp Asn

C26H38N8O7 (574.2863)

Gln Lys Tyr His

C26H38N8O7 (574.2863)

Gln Asn Lys Trp

C26H38N8O7 (574.2863)

Gln Asn Trp Lys

C26H38N8O7 (574.2863)

Gln Trp Lys Asn

C26H38N8O7 (574.2863)

Gln Trp Asn Lys

C26H38N8O7 (574.2863)

Gln Tyr His Lys

C26H38N8O7 (574.2863)

Gln Tyr Lys His

C26H38N8O7 (574.2863)

Arg Asp Val Trp

C26H38N8O7 (574.2863)

Arg Asp Trp Val

C26H38N8O7 (574.2863)

Arg Phe Pro Arg

C26H42N10O5 (574.3339)

Arg Phe Arg Pro

C26H42N10O5 (574.3339)

Arg Ile Met Arg

C23H46N10O5S (574.3373)

Arg Ile Arg Met

C23H46N10O5S (574.3373)

Arg Ile Thr Trp

C27H42N8O6 (574.3227)

Arg Ile Trp Thr

C27H42N8O6 (574.3227)

Arg Leu Met Arg

C23H46N10O5S (574.3373)

Arg Leu Arg Met

C23H46N10O5S (574.3373)

Arg Leu Thr Trp

C27H42N8O6 (574.3227)

Arg Leu Trp Thr

C27H42N8O6 (574.3227)

Arg Met Ile Arg

C23H46N10O5S (574.3373)

Arg Met Leu Arg

C23H46N10O5S (574.3373)

Arg Met Arg Ile

C23H46N10O5S (574.3373)

Arg Met Arg Leu

C23H46N10O5S (574.3373)

Arg Pro Phe Arg

C26H42N10O5 (574.3339)

Arg Pro Arg Phe

C26H42N10O5 (574.3339)

Arg Arg Phe Pro

C26H42N10O5 (574.3339)

Arg Arg Ile Met

C23H46N10O5S (574.3373)

Arg Arg Leu Met

C23H46N10O5S (574.3373)

Arg Arg Met Ile

C23H46N10O5S (574.3373)

Arg Arg Met Leu

C23H46N10O5S (574.3373)

Arg Arg Pro Phe

C26H42N10O5 (574.3339)

Arg Thr Ile Trp

C27H42N8O6 (574.3227)

Arg Thr Leu Trp

C27H42N8O6 (574.3227)

Arg Thr Trp Ile

C27H42N8O6 (574.3227)

Arg Thr Trp Leu

C27H42N8O6 (574.3227)

Arg Val Asp Trp

C26H38N8O7 (574.2863)

Arg Val Trp Asp

C26H38N8O7 (574.2863)

Arg Trp Asp Val

C26H38N8O7 (574.2863)

Arg Trp Ile Thr

C27H42N8O6 (574.3227)

Arg Trp Leu Thr

C27H42N8O6 (574.3227)

Arg Trp Thr Ile

C27H42N8O6 (574.3227)

Arg Trp Thr Leu

C27H42N8O6 (574.3227)

Arg Trp Val Asp

C26H38N8O7 (574.2863)

Thr Ile Arg Trp

C27H42N8O6 (574.3227)

Thr Ile Trp Arg

C27H42N8O6 (574.3227)

Thr Leu Arg Trp

C27H42N8O6 (574.3227)

Thr Leu Trp Arg

C27H42N8O6 (574.3227)

Thr Arg Ile Trp

C27H42N8O6 (574.3227)

Thr Arg Leu Trp

C27H42N8O6 (574.3227)

Thr Arg Trp Ile

C27H42N8O6 (574.3227)

Thr Arg Trp Leu

C27H42N8O6 (574.3227)

Thr Trp Ile Arg

C27H42N8O6 (574.3227)

Thr Trp Leu Arg

C27H42N8O6 (574.3227)

Thr Trp Arg Ile

C27H42N8O6 (574.3227)

Thr Trp Arg Leu

C27H42N8O6 (574.3227)

Val Asp Arg Trp

C26H38N8O7 (574.2863)

Val Asp Trp Arg

C26H38N8O7 (574.2863)

Val Arg Asp Trp

C26H38N8O7 (574.2863)

Val Arg Trp Asp

C26H38N8O7 (574.2863)

Val Trp Asp Arg

C26H38N8O7 (574.2863)

Val Trp Arg Asp

C26H38N8O7 (574.2863)

Trp Ala Ile Trp

C31H38N6O5 (574.2904)

Trp Ala Leu Trp

C31H38N6O5 (574.2904)

Trp Ala Trp Ile

C31H38N6O5 (574.2904)

Trp Ala Trp Leu

C31H38N6O5 (574.2904)

Trp Asp Arg Val

C26H38N8O7 (574.2863)

Trp Asp Val Arg

C26H38N8O7 (574.2863)

Trp Glu Ile Lys

C28H42N6O7 (574.3115)

Trp Glu Lys Ile

C28H42N6O7 (574.3115)

Trp Glu Lys Leu

C28H42N6O7 (574.3115)

Trp Glu Leu Lys

C28H42N6O7 (574.3115)

Trp Ile Ala Trp

C31H38N6O5 (574.2904)

Trp Ile Glu Lys

C28H42N6O7 (574.3115)

Trp Ile Lys Glu

C28H42N6O7 (574.3115)

Trp Ile Arg Thr

C27H42N8O6 (574.3227)

Trp Ile Thr Arg

C27H42N8O6 (574.3227)

Trp Ile Trp Ala

C31H38N6O5 (574.2904)

Trp Lys Glu Ile

C28H42N6O7 (574.3115)

Trp Lys Glu Leu

C28H42N6O7 (574.3115)

Trp Lys Ile Glu

C28H42N6O7 (574.3115)

Trp Lys Lys Asn

C27H42N8O6 (574.3227)

Trp Lys Leu Glu

C28H42N6O7 (574.3115)

Trp Lys Asn Lys

C27H42N8O6 (574.3227)

Trp Lys Asn Gln

C26H38N8O7 (574.2863)

Trp Lys Gln Asn

C26H38N8O7 (574.2863)

Trp Leu Ala Trp

C31H38N6O5 (574.2904)

Trp Leu Glu Lys

C28H42N6O7 (574.3115)

Trp Leu Lys Glu

C28H42N6O7 (574.3115)

Trp Leu Arg Thr

C27H42N8O6 (574.3227)

Trp Leu Thr Arg

C27H42N8O6 (574.3227)

Trp Leu Trp Ala

C31H38N6O5 (574.2904)

Trp Asn Lys Lys

C27H42N8O6 (574.3227)

Trp Asn Lys Gln

C26H38N8O7 (574.2863)

Trp Asn Gln Lys

C26H38N8O7 (574.2863)

Trp Gln Lys Asn

C26H38N8O7 (574.2863)

Trp Gln Asn Lys

C26H38N8O7 (574.2863)

Trp Arg Asp Val

C26H38N8O7 (574.2863)

Trp Arg Ile Thr

C27H42N8O6 (574.3227)

Trp Arg Leu Thr

C27H42N8O6 (574.3227)

Trp Arg Thr Ile

C27H42N8O6 (574.3227)

Trp Arg Thr Leu

C27H42N8O6 (574.3227)

Trp Arg Val Asp

C26H38N8O7 (574.2863)

Trp Thr Ile Arg

C27H42N8O6 (574.3227)

Trp Thr Leu Arg

C27H42N8O6 (574.3227)

Trp Thr Arg Ile

C27H42N8O6 (574.3227)

Trp Thr Arg Leu

C27H42N8O6 (574.3227)

Trp Val Asp Arg

C26H38N8O7 (574.2863)

Trp Val Arg Asp

C26H38N8O7 (574.2863)

Trp Trp Ala Ile

C31H38N6O5 (574.2904)

Trp Trp Ala Leu

C31H38N6O5 (574.2904)

Trp Trp Ile Ala

C31H38N6O5 (574.2904)

Trp Trp Leu Ala

C31H38N6O5 (574.2904)

Tyr His Lys Lys

C27H42N8O6 (574.3227)

Tyr His Lys Gln

C26H38N8O7 (574.2863)

Tyr His Gln Lys

C26H38N8O7 (574.2863)

Tyr Lys His Lys

C27H42N8O6 (574.3227)

Tyr Lys His Gln

C26H38N8O7 (574.2863)

Tyr Lys Lys His

C27H42N8O6 (574.3227)

Tyr Lys Gln His

C26H38N8O7 (574.2863)

Tyr Gln His Lys

C26H38N8O7 (574.2863)

Tyr Gln Lys His

C26H38N8O7 (574.2863)

TPTEK

C24H42N6O10 (574.2962)

ADLEK

C24H42N6O10 (574.2962)

ELKGE

C24H42N6O10 (574.2962)

TEGLR

C23H42N8O9 (574.3075)

DALRT

C23H42N8O9 (574.3075)

EEVKA

C24H42N6O10 (574.2962)

LREGT

C23H42N8O9 (574.3075)

KDLSL

C25H46N6O9 (574.3326)

KNNTV

C23H42N8O9 (574.3075)

ERIAS

C23H42N8O9 (574.3075)

IIRSS

C24H46N8O8 (574.3438)

OKOHA-PA

C28H47O10P (574.2907)

ST 32:6;O9

C32H46O9 (574.3142)

RGDFV Peptide, Cyclic

C26H38N8O7 (574.2863)

tri-(2-tert-butyl-4-methylphenyl)phosphite

C33H51O6P (574.3423)

Fmoc-Lys(ivDde)-OH

C34H42N2O6 (574.3043)

AFDX384

C28H42N6O5S (574.2937)

1,1-(decane-1,10-diyl)bis[4-amino-2-methylquinolinium] diacetate

C34H46N4O4 (574.3519)

N-{4-[(1-Hydroxycarbamoyl-2-methyl-propyl)-(2-morpholin-4-YL-ethyl)-sulfamoyl]-4-pentyl-benzamide

C29H42N4O6S (574.2825)

herbimycin a

C30H42N2O9 (574.289)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

18-Hydroxy-chi,chi-caroten-18-oic acid

C40H46O3 (574.3447)

ergothioneyl-N-demethyllincomycin

C25H44N5O8S+ (574.291)

[(E,6R)-6-[(2S,9R,10R,13R,14S,16R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H46O9 (574.3142)

[(2S,3R,4R,5S)-2-[(1S,2R,4R,5S,7S,11S,12S,15R,16S)-4,5-dihydroxy-2,16-dimethyl-8-oxo-9-oxatetracyclo[9.7.0.02,7.012,16]octadecan-15-yl]-5-ethyl-4-hydroxy-6-methylheptan-3-yl] hydrogen sulfate

C29H50O9S (574.3175)

[(1S)-1-carboxy-2-[2-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-hydroxy-1-[[(2S,4R)-4-propylpyrrolidine-2-carbonyl]amino]propyl]oxan-2-yl]sulfanyl-1H-imidazol-5-yl]ethyl]-trimethylazanium

C25H44N5O8S+ (574.291)

[(4Z,6E,10E)-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate

C30H42N2O9 (574.289)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

PA(8:0/18:2(10E,12Z)+=O(9))

C29H51O9P (574.3271)

PA(18:2(10E,12Z)+=O(9)/8:0)

C29H51O9P (574.3271)

PA(8:0/18:2(9Z,11E)+=O(13))

C29H51O9P (574.3271)

PA(18:2(9Z,11E)+=O(13)/8:0)

C29H51O9P (574.3271)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H51O9P (574.3271)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H51O9P (574.3271)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H51O9P (574.3271)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H51O9P (574.3271)

7,8-Dehydrocerberin

C32H46O9 (574.3142)

A cardenolide glycoside that is the 7,8-dehydroderivative of cerberin. Isolated from Cerbera manghas, it exhibits cytotoxic activity.

2-[(2R,5S,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

C26H38N8O7 (574.2863)

(6R)-6-[(3S,10S,13R,14R,15R,17R)-12-acetyloxy-3,15-dihydroxy-4,4,10,13,14-pentamethyl-7,11-dioxo-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide

C34H46N4O4 (574.3519)

Isodiotigenin triacetate

C33H50O8 (574.3506)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C28H47O10P (574.2907)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C28H47O10P (574.2907)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C28H47O10P (574.2907)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C28H47O10P (574.2907)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C28H47O10P (574.2907)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C28H47O10P (574.2907)

2-(3,4-Dimethoxyphenyl)ethyl 2,3,4-tri-O-methyl-alpha-(L)-rhamnopyranosyl(1.rar.3)-2,4,6-tri-O-methyl-beta-(D)-glucopyranoside

C28H46O12 (574.2989)

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H53NO8P+ (574.3509)

2-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C29H53NO8P+ (574.3509)

DGGA 20:1

C29H50O11 (574.3353)

PA O-25:5;O3

C28H47O10P (574.2907)

PA O-26:4;O2

C29H51O9P (574.3271)

PA P-18:0/8:3;O2

C29H51O9P (574.3271)

PA P-18:1/7:3;O3

C28H47O10P (574.2907)

PA P-18:1/8:2;O2

C29H51O9P (574.3271)

PA 14:0/12:3;O

C29H51O9P (574.3271)

PA 16:0/9:4;O2

C28H47O10P (574.2907)

PA 18:0/8:3;O

C29H51O9P (574.3271)

PA 18:1/7:3;O2

C28H47O10P (574.2907)

PA 18:2/7:2;O2

C28H47O10P (574.2907)

PA 18:2/8:1;O

C29H51O9P (574.3271)

PA 20:1/6:2;O

C29H51O9P (574.3271)

PA 20:3/5:1;O2

C28H47O10P (574.2907)

PA 22:2/4:1;O

C29H51O9P (574.3271)

PA 26:3;O

C29H51O9P (574.3271)

LPG 22:5;O

C28H47O10P (574.2907)

PG 18:3/4:1

C28H47O10P (574.2907)

PG 18:4/4:0

C28H47O10P (574.2907)

PG 20:4/2:0

C28H47O10P (574.2907)

PG 22:4

C28H47O10P (574.2907)

PEth 24:3;O

C29H51O9P (574.3271)

PM 25:3;O

C29H51O9P (574.3271)

ST 22:0;O6;GlcA

C28H46O12 (574.2989)

ST 26:4;O3;GlcA

C32H46O9 (574.3142)

ST 27:3;O2;GlcA

C33H50O8 (574.3506)

ST 22:1;O7;Hex

C28H46O12 (574.2989)

ST 23:0;O6;Hex

C29H50O11 (574.3353)

ST 26:5;O4;Hex

C32H46O9 (574.3142)

ST 27:4;O3;Hex

C33H50O8 (574.3506)

ST 29:1;O6;S

C29H50O9S (574.3175)

1-[3-(2-{5-hydroxy-1,6,6-trimethyl-4-oxo-3,7-dioxaspiro[bicyclo[3.2.1]octane-2,2'-oxan]-5'-yl}ethyl)-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15bs)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,5r,5's)-5-hydroxy-1,6,6-trimethyl-4-oxo-3,7-dioxaspiro[bicyclo[3.2.1]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

5,7-dihydroxy-2-{1-hydroxy-5-[(3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-6-methyl-2-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl}chromen-4-one

C35H42O7 (574.293)

[(1s,9s,10r,11r,17s)-12-{[(4r,12r,13s,16s,17r,18s,20r,21e)-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-21-ylidene]methyl}-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,12-tetraen-10-yl]methanol

C37H42N4O2 (574.3308)

(1r,2r,5s,6r,10r,11s,12s,15r,16r,18s,19r)-16-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-18-yl benzoate

C35H42O7 (574.293)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15br)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1s)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(6r)-6-[(3r,3ar,7s)-3,7-dihydroxy-3a,6,6,9a,11,11a-hexamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-(acetyloxy)-2-methyl-4-oxohexanoic acid

C32H46O9 (574.3142)

6-[(3as,4r,7r,9ar,11r,11as)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

14-(4-hydroxy-5,6-dimethyl-3-oxoheptan-2-yl)-2,15-dimethyl-9-oxo-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-7-en-5-yl 2,3-dihydroxy-3-methylbutanoate

C33H50O8 (574.3506)

8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7-dihydroxy-3,6-bis(3-methylbut-2-en-1-yl)-2-(2,4,5-trihydroxyphenyl)chromen-4-one

C35H42O7 (574.293)

(3r)-3-[(2r,3r,6s)-4-hydroxy-2,3-dimethyl-6-[(2r)-5-methyl-2-(2-methylprop-1-en-1-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C36H46O6 (574.3294)

2-[2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

2'-o-acetyl cerleaside a

C32H46O9 (574.3142)

{"Ingredient_id": "HBIN006174","Ingredient_name": "2'-o-acetyl cerleaside a","Alias": "NA","Ingredient_formula": "C32H46O9","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC45C3CCC(C4=O)(C(CC5)C6=CC(=O)OC6)C)C)OC(=O)C)OC)O","Ingredient_weight": "574.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "349","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101338813","DrugBank_id": "NA"}

3β-o-(2'-o-acetyl-α-l-thevetosyl)-14β-hy-droxy-7-en-5β-card-20(22)-enolide

C32H46O9 (574.3142)

{"Ingredient_id": "HBIN008278","Ingredient_name": "3\u03b2-o-(2'-o-acetyl-\u03b1-l-thevetosyl)-14\u03b2-hy-droxy-7-en-5\u03b2-card-20(22)-enolide","Alias": "NA","Ingredient_formula": "C32H46O9","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4=CCC3C2)O)C6=CC(=O)OC6)C)C)OC(=O)C)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2s)-1-[(2s)-2-[(2s,3r)-2-{[(2r,3r)-3-amino-10-chloro-1,2-dihydroxydecylidene]amino}-n,3-dimethylpentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C28H51ClN4O6 (574.3497)

(2s)-1-[(2s)-2-[(2s,3s)-2-{[(2r,3r)-3-amino-10-chloro-1,2-dihydroxydecylidene]amino}-n,3-dimethylpentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C28H51ClN4O6 (574.3497)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13br,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

{[(4z,6e,8s,9s,10e,12s,13r,14s,16s,17r)-3-hydroxy-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-20,22-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

C30H42N2O9 (574.289)

9-(1-hydroxyethyl)-3-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-13-ene-7,11-dione

C32H46O9 (574.3142)

1,4-dihydroxy-9a,11a-dimethyl-1-(1-{5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C32H46O7S (574.2964)

8-(acetyloxy)-3-hydroxy-4',5,5',5',19-pentamethyl-21-oxo-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H46O9 (574.3142)

2-{[3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-1h,2h,3h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

methyl 3-{5-hydroxy-2,3-dimethyl-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-8-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-6-yl}-3-phenylpropanoate

C36H46O6 (574.3294)

(2r,3s,4r,5s,6s)-2-{[(1r,4r,6s,9s,10r,13r,14r)-9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1s,2s,4r,5r,6r,11r,12r,16r,18s,21r)-2,9,11-trihydroxy-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-9,13-dien-8-one

C32H46O9 (574.3142)

({19-formyl-20,22-dihydroxy-8,13,14-trimethoxy-4,10,12,16-tetramethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl}oxy)methanimidic acid

C30H42N2O9 (574.289)

2-(5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-6-methyl-2-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl)-5,7-dihydroxychromen-4-one

C35H42O7 (574.293)

(1r,3as,3br,4r,9ar,9bs,11as)-1,4-dihydroxy-9a,11a-dimethyl-1-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C32H46O7S (574.2964)

methyl 7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(6r)-6-[(1r,3r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

methyl (5ar,6r,7s,7as,7br,9as,13as,13br,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

6-ethyl-8',9'-dihydroxy-10'-(hydroxymethyl)-7'-methoxy-5,6',14',16'-tetramethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-5',10',12',16'-tetraen-3'-one

C33H50O8 (574.3506)

16-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-18-yl benzoate

C35H42O7 (574.293)

2,9,11-trihydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-9,13-dien-8-one

C32H46O9 (574.3142)

2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9bs,11ar)-2,4-bis(acetyloxy)-5,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

{[(4e,6e,8s,9r,10e,12r,13s,14r,16r)-19-formyl-3,20,22-trihydroxy-8,13,14-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18(22),19-heptaen-9-yl]oxy}methanimidic acid

C30H42N2O9 (574.289)

(2s,4ar,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-10-(acetyloxy)-11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C33H50O8 (574.3506)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,4r,5's)-4-hydroxy-1,5,5-trimethyl-8-oxo-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

(1''r,2''r,8''r,9's,9'as,10''s,11''r,12''s,16''s)-2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-3''-en-10''-yl acetate

C34H42N2O6 (574.3043)

methyl (5ar,6r,7s,7as,7br,9as,13as,13br,15as,15bs)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(6r)-6-[(1r,3ar,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

6,14-dihydroxy-5,5-bis(hydroxymethyl)-9-methyl-14-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C28H46O12 (574.2989)

{[(4e,6e,8s,9s,10e,12s,13r,14s,16s,17r)-3-hydroxy-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-20,22-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

C30H42N2O9 (574.289)

(2r,3s,4r,5s,6s)-2-{[(1s,4r,6s,9s,10r,13r,14r)-9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(2r,3s,4r,5s,6s)-2-{[(1s,4r,6s,9s,10r,14r)-9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-13-(acetyloxy)-4-hydroxy-3,6,6,10,14-pentamethyl-9-[(2-methylbutanoyl)oxy]-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C32H46O9 (574.3142)

methyl 7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1r,2s,5s,10r,11s,14r,15r,17r)-14-[(2s,4s,5r)-4-hydroxy-5,6-dimethyl-3-oxoheptan-2-yl]-2,15-dimethyl-9-oxo-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-7-en-5-yl 2,3-dihydroxy-3-methylbutanoate

C33H50O8 (574.3506)

3-[(1s,2r,3br,4r,5ar,9as,9br,10r,11as)-2,4,10-trihydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

C32H46O9 (574.3142)

(1r,4s,6r,9s,10s,13r,14r,15r)-6,14-dihydroxy-5,5-bis(hydroxymethyl)-9-methyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C28H46O12 (574.2989)

1-(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n,3-dimethylpentanamido}-4-methylpentanoyl)pyrrolidine-2-carboxylic acid

C28H51ClN4O6 (574.3497)

6-[11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-3''-en-10''-yl acetate

C34H42N2O6 (574.3043)

methyl (3s)-3-[(2r,3r,8r)-5-hydroxy-2,3-dimethyl-8-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-8-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-6-yl]-3-phenylpropanoate

C36H46O6 (574.3294)

6-[11-(acetyloxy)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(1s,3r,4s,5s,9r)-9-[(1r)-1-hydroxyethyl]-3-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-13-ene-7,11-dione

C32H46O9 (574.3142)

butyl 4-[11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate

C33H50O8 (574.3506)

2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9br,11ar)-2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

{[(4e,6z,8s,9s,10e,12s,13r,14s,16s,17r)-3-hydroxy-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-20,22-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

C30H42N2O9 (574.289)

butyl (4r)-4-[(1r,3ar,4s,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate

C33H50O8 (574.3506)

(2r,3r,4s,5s,6r)-2-[(2r,3r)-3-[(1r,3r,4r,9s,10r,13s,14s,15s)-3,14-dihydroxy-15-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]-2,3-dihydroxypropoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C29H50O11 (574.3353)

2-{[9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

3-{4-hydroxy-2,3-dimethyl-6-[5-methyl-2-(2-methylprop-1-en-1-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl}-3-phenylpropanoic acid

C36H46O6 (574.3294)

2-[(4ar,5r,8ar)-5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-6-methyl-2-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl]-5,7-dihydroxychromen-4-one

C35H42O7 (574.293)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

{[(4z,6z,8s,9s,10z,12s,13r,14s,16s)-19-formyl-3,20,22-trihydroxy-8,13,14-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18(22),19-heptaen-9-yl]oxy}methanimidic acid

C30H42N2O9 (574.289)

2-{3-[3,14-dihydroxy-15-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]-2,3-dihydroxypropoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C29H50O11 (574.3353)

methyl 6-(acetyloxy)-7,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

2-{[3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(2r,3r,4r,5s,6s)-2-{[(3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1r,3s,4s,4's,5s,7r,8s,10s,13s,14s,16s,18s,19r,22r)-8-(acetyloxy)-3-hydroxy-4',5,5',5',19-pentamethyl-21-oxo-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H46O9 (574.3142)

(3r)-3-[(2s,3r,6s)-4-hydroxy-2,3-dimethyl-6-[(2r)-5-methyl-2-(2-methylprop-1-en-1-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C36H46O6 (574.3294)

(1's,2s,4'r,5r,6s,8's,10'e,12's,13'r,14'e,16'e,20'r,21's,24'r)-6-ethyl-12',21',24'-trihydroxy-11'-(hydroxymethyl)-5,13',22'-trimethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-one

C32H46O9 (574.3142)

(3e,6r)-6-[(1r,2r,3as,3bs,4s,8s,9ar,9bs,11ar)-2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H46O9 (574.3142)

6-hydroxy-2-methyl-5-oxo-6-{2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-yl acetate

C32H46O9 (574.3142)

6-hydroxy-7,7-dimethyl-5-oxo-3-{2,4,10-trihydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}oxepan-2-yl acetate

C32H46O9 (574.3142)

(1s,3ar,3bs,4r,9as,9bs,11ar)-4-hydroxy-1-[(1s)-1-[(1s,3r,5r)-1-[(1r)-1-hydroxy-2-(methylsulfanyl)-2-oxoethyl]-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C32H46O7S (574.2964)

(2r,6r)-6-[(1s,3ar,4s,5ar,7s,9as,11s,11as)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(2r,6r)-6-[(1r,2s,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-2,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,4r,5'r)-4-hydroxy-1,5,5-trimethyl-8-oxo-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

(1s,3as,3br,7s,9ar,9bs,11r,11as)-1-acetyl-3a-hydroxy-7-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-2-methylbut-2-enoate

C33H50O8 (574.3506)

methyl 6-(acetyloxy)-7,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1r,2r,5s,6r,10r,11s,12r,15r,16r,18s,19r)-16-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-18-yl benzoate

C35H42O7 (574.293)

2-[2,4-bis(acetyloxy)-5,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

10-(acetyloxy)-11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C33H50O8 (574.3506)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13bs,15as,15bs)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

2-[(1r,4ar,5s,8ar)-5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-6-methyl-2-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl]-5,7-dihydroxychromen-4-one

C35H42O7 (574.293)

1-(2-{[2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-n-(5-carbamimidamido-1-oxopentan-2-yl)pyrrolidine-2-carboximidic acid

C28H42N6O7 (574.3115)

(2r,6s)-6-[(1s,3ar,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(1r,3s,4r,5r,9s)-9-[(1s)-1-hydroxyethyl]-3-[(2r,5r)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-13-ene-7,11-dione

C32H46O9 (574.3142)

(2r,6r)-6-[(1r,3ar,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

6-[2,8-dihydroxy-9b-(hydroxymethyl)-3a,6,6,11a-tetramethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H46O9 (574.3142)

1-[3-(2-{4-hydroxy-1,5,5-trimethyl-8-oxo-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl}ethyl)-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

8-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-3,6-bis(3-methylbut-2-en-1-yl)-2-(2,4,5-trihydroxyphenyl)chromen-4-one

C35H42O7 (574.293)

(1's,2r,4'r,5s,6r,7'r,8'r,9's,10'e,12'e,14'r,16'e,19'r)-6-ethyl-8',9'-dihydroxy-10'-(hydroxymethyl)-7'-methoxy-5,6',14',16'-tetramethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-5',10',12',16'-tetraen-3'-one

C33H50O8 (574.3506)

4-hydroxy-1-(1-{1-[1-hydroxy-2-(methylsulfanyl)-2-oxoethyl]-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C32H46O7S (574.2964)